PL2902384T3 - Postać chlorowodorku iwabradyny - Google Patents

Postać chlorowodorku iwabradyny

Info

Publication number
PL2902384T3
PL2902384T3 PL15151073T PL15151073T PL2902384T3 PL 2902384 T3 PL2902384 T3 PL 2902384T3 PL 15151073 T PL15151073 T PL 15151073T PL 15151073 T PL15151073 T PL 15151073T PL 2902384 T3 PL2902384 T3 PL 2902384T3
Authority
PL
Poland
Prior art keywords
ivabradine hydrochloride
ivabradine
hydrochloride
Prior art date
Application number
PL15151073T
Other languages
English (en)
Inventor
Berta Kotar-Jordan
Urska Gojak
Matej Smrkolj
Original Assignee
Krka, D.D., Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka, D.D., Novo Mesto filed Critical Krka, D.D., Novo Mesto
Publication of PL2902384T3 publication Critical patent/PL2902384T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
PL15151073T 2010-02-12 2011-02-11 Postać chlorowodorku iwabradyny PL2902384T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI201000057 2010-02-12
EP11702672A EP2534135A2 (en) 2010-02-12 2011-02-11 Novel forms of ivabradine hydrochloride
EP15151073.2A EP2902384B1 (en) 2010-02-12 2011-02-11 Form of ivabradine hydrochloride

Publications (1)

Publication Number Publication Date
PL2902384T3 true PL2902384T3 (pl) 2018-04-30

Family

ID=43770633

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15151073T PL2902384T3 (pl) 2010-02-12 2011-02-11 Postać chlorowodorku iwabradyny

Country Status (6)

Country Link
EP (2) EP2534135A2 (pl)
EA (1) EA201290772A1 (pl)
HU (1) HUE035588T2 (pl)
PL (1) PL2902384T3 (pl)
SI (2) SI23290A (pl)
WO (1) WO2011098582A2 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8900605B2 (en) * 2010-06-14 2014-12-02 Ratiopharm Gmbh Solid ivabradine-containing composition
WO2012025940A1 (en) * 2010-08-25 2012-03-01 Cadila Healthcare Limited Polymorphic form of ivabradine hydrochloride and process for preparation thereof
MX2014001556A (es) 2011-08-12 2014-03-31 Boehringer Ingelheim Vetmed Composicion farmaceutica de sabor enmascarado.
EP2589594A1 (en) * 2011-11-04 2013-05-08 Urquima S.A. Ivabradine hydrochloride Form IV
EP2780327A1 (en) 2011-11-14 2014-09-24 Cadila Healthcare Limited Polymorphic forms of ivabradine hydrochloride
IN2012CH01309A (pl) * 2012-04-02 2015-06-19 Hetero Research Foundation
WO2014024210A2 (en) * 2012-08-10 2014-02-13 Hetero Research Foundation Novel polymorphs of doxercalciferol
WO2014122248A1 (en) 2013-02-11 2014-08-14 Boehringer Ingelheim Vetmedica Gmbh Kit-of-parts
ITMI20130416A1 (it) * 2013-03-19 2014-09-20 Chemo Res S L Nuovo polimorfo del cloridrato di ivabradina e metodo per la sua preparazione
EP2781509B2 (en) 2013-03-19 2023-06-14 Chemo Research, S.L. New polymorph of ivabradine hydrochloride and method for its preparation
WO2015001569A1 (en) * 2013-07-02 2015-01-08 Genepharm India Private Limited A solid pharmaceutical composition of ivabradine for oral administration
CZ305096B6 (cs) 2013-10-02 2015-04-29 Zentiva, K.S. Pevná forma Ivabradin hydrochloridu a (S)-mandlové kyseliny a její farmaceutická kompozice
WO2015001133A1 (en) 2013-12-12 2015-01-08 Synthon B.V. Pharmaceutical composition comprising amorphous ivabradine
WO2015091992A1 (en) * 2013-12-20 2015-06-25 Synthon B.V. Pharmaceutical composition comprising amorphous ivabradine
ES2717715T3 (es) * 2014-02-14 2019-06-24 Synthon Bv Composición farmacéutica que comprende polimorfo IV de clorhidrato de ivabradina
EP3122362A1 (en) * 2014-03-27 2017-02-01 Laboratorio Chimico Internazionale S.p.A. Ivabradine adsorbates
CZ2014478A3 (cs) 2014-07-10 2015-09-16 Zentiva, K.S. Pevná forma Ivabradin hydrochloridu a (R)-mandlové kyseliny a její farmaceutická kompozice
WO2017005844A1 (en) 2015-07-07 2017-01-12 Janssen Vaccines & Prevention B.V. Vaccine against rsv
TR201703066A2 (tr) * 2017-02-28 2018-09-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi İvabradi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari
EP3366282A1 (en) * 2017-02-28 2018-08-29 Sanovel Ilac Sanayi ve Ticaret A.S. Solid oral pharmaceutical compositions of ivabradine
IT202000025312A1 (it) 2020-10-26 2022-04-26 Cambrex Profarmaco Milano S R L Processi per la preparazione di polimorfi di ivabradina hcl
WO2023094048A1 (en) * 2021-11-24 2023-06-01 Nutrition & Biosciences Usa 1, Llc Process for producing microcrystalline cellulose with reduced nitrite salt content

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (fr) 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868777B1 (fr) 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868776B1 (fr) 2004-04-13 2008-04-18 Servier Lab Nouveau procede de synthese de derives de la 1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868775B1 (fr) 2004-04-13 2008-04-11 Servier Lab Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2870537A1 (fr) 2004-05-19 2005-11-25 Servier Lab Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2882555B1 (fr) 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882553B1 (fr) 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882554B1 (fr) 2005-02-28 2007-05-04 Servier Lab Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2891826B1 (fr) 2005-10-11 2007-12-28 Servier Lab Forme cristalline 6 du chlorhydrate de l'ivabradine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2891827B1 (fr) 2005-10-11 2007-12-28 Servier Lab Forme cristalline deltad du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
ES2381771T3 (es) 2006-11-30 2012-05-31 Cadila Healthcare Limited Procedimiento para la preparación de hidrocloruro de ivabradina
WO2008125006A1 (fr) 2007-04-12 2008-10-23 Utopharm (Shanghai) Co., Ltd Procédés de préparation du chlorhydrate d'ivabradine et de sa forme cristalline stable
EP2471780B1 (en) 2007-05-30 2014-11-26 Ind-Swift Laboratories Limited Crystalline Ivabradine Oxalate Salts and Polymorphs Thereof
CN101434552B (zh) 2007-11-16 2012-05-23 江苏恒瑞医药股份有限公司 4,5-二甲氧基-1-(甲基氨基甲基)-苯并环丁烷的拆分
CN101544605A (zh) 2008-03-24 2009-09-30 北京深蓝海生物医药科技有限公司 伊伐布雷定及其药学上可接受的加成盐的制备方法
CN101343249A (zh) 2008-06-10 2009-01-14 上海医药工业研究院 3－(3－氯丙基)－7,8－二甲氧基－1,3－二氢－2h－3－苯并氮杂－2－酮的制备方法
FR2932800B1 (fr) 2008-06-20 2015-02-20 Servier Lab Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2933975B1 (fr) 2008-07-17 2011-02-18 Servier Lab Nouveau procede de preparation de benzocyclobutenes fonctionnalises,et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.

Also Published As

Publication number Publication date
EA201290772A1 (ru) 2013-02-28
SI2902384T1 (en) 2018-03-30
HUE035588T2 (en) 2018-05-28
WO2011098582A2 (en) 2011-08-18
SI23290A (sl) 2011-08-31
EP2902384A1 (en) 2015-08-05
WO2011098582A3 (en) 2012-03-01
EP2534135A2 (en) 2012-12-19
EP2902384B1 (en) 2017-11-08

Similar Documents

Publication Publication Date Title
PL2902384T3 (pl) Postać chlorowodorku iwabradyny
ZA201209407B (en) Modification of xylan
HRP20211969T1 (hr) Farmaceutski pripravak karbetocina
HK1171476A1 (en) Apparatuses
ZA201403073B (en) Ivabradine hydrochloride form iv
EP2648519A4 (en) NEW POLYMORPH OF NILOTINIB HYDROCHLORIDE
GB2497476B (en) Amide Compounds
ME02102B (me) Novi polimorf
EP2601200A4 (en) PREPARATION FROM PRASUGRELHYDROCHLORIDE
EP2757881A4 (en) KAPPA OPIOID RECEPTOR EFFECTORS AND USES THEREOF
EP2520562A4 (en) ANTI-LEISHMANIA COMPOUND AND ANTI-LEISHMANIA MEDICINES
TWM385548U (en) Improved structure of conveyor
PL395425A1 (pl) Sposób wytwarzania chlorowodorku 2-amino-N-tert-butylo-2- cyjanoacetamidu
TWM400763U (en) Improved structure of cold-accumulating cravats
TWM388315U (en) Improved structure of hemoclip
TWM385568U (en) Structure of net-washing machine
TWM390349U (en) Structure of door-in-door
TWM386865U (en) Residue-filtering structure of juice-extractor
TWM390745U (en) Structure improvement of tea-making can
TWM401632U (en) Structure of bottle
TWM385541U (en) Improved structure of container
TWM400817U (en) Improved structure of pillow
TWM402612U (en) Improved structure of connection member
TWM401944U (en) Improved structure of speaker
HU1000688D0 (en) Use of trifluoro-phal